Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency

Journal of Endocrinological Investigation

Volumn 35, Issue 4, 2012, Pages 407-412

  Rendina, D ^a,b   De Filippo, G ^a   Mossetti, G ^a   Zampa, G ^a   Muscariello, R ^a   Benvenuto, G ^b   Vivona, C L ^b   Ippolito, S ^a   Galante, F ^a   Lombardi, G ^a   Biondi, B ^a   Strazzullo, P ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Spinelli Hospital   (Turkey)

Author keywords

Cross sectional study; Fine needle aspiration biopsy; Goiter; Metabolic syndrome; Ultrasound scan

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PIOGLITAZONE; SULFONYLUREA;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; ASPIRATION BIOPSY; BIOGEOGRAPHIC REGION; BODY MASS; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORGAN SIZE; PARITY; RISK FACTOR; SEX DIFFERENCE; THYROID FUNCTION; THYROID GLAND; THYROID NODULE; TOBACCO DEPENDENCE; TOXIC GOITER;

AGED; AGED, 80 AND OVER; FEMALE; GOITER, NODULAR; HOSPITALIZATION; HUMANS; IODINE; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 84863932611     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7842     Document Type: Article

References (35)

1. Hegedüs L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003, 24: 102-32. (Pubitemid 36223282)
2. Krohn K, Führer D, Bayer Y, et al. Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 2005, 26: 504-24. (Pubitemid 41014264)
3. Hansen PS, Brix TH, Bennedbaek FN, et al. The relative importance of genetic and environmental factors in the aetiology of thyroid nodularity: a study of healthy Danish twins. Clin Endocrinol (Oxf) 2005, 62: 380-6. (Pubitemid 40380423)
4. Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev 2008, 29: 777-822.
5. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007, 17: 319-26. (Pubitemid 46551691)
6. Grundy SM, Cleeman JI, Daniels SR, et al; American Heart As sociation; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112: 2735-52. (Pubitemid 41532612)
7. Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 2009, 94: 1853-78.
8. Hegedüs L, Perrild H, Poulsen LR, et al. The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 1983, 56: 260-3. (Pubitemid 13184359)
9. Gómez JM, Maravall FJ, Gómez N, Gumà A, Casamitjana R, Soler J. Pituitary-thyroid axis, thyroid volume and leptin in healthy adults. Horm Metab Res 2002, 34: 67-71. (Pubitemid 34208312)
10. Junik R, Kozinski M, Debska-Kozinska K. Thyroid ultrasound in diabetic patients without overt thyroid disease. Acta Radiol 2006, 47: 687-91. (Pubitemid 44358960)
11. Gómez JM, Maravall FJ, Gumà A, Abós R, Soler J, Fernández-Castañer M. Thyroid volume as measured by ultrasonography in patients with type 1 diabetes mellitus without thyroid dysfunction Horm Metab Res 2003, 35: 486-91. (Pubitemid 37204565)
12. Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 2008, 18: 461-4. (Pubitemid 351519543)
13. Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Eur J Endocrinol 2009, 161: 599-605.
14. Costante G, Grasso L, Schifino E, et al. Iodine deficiency in Calabria: characterization of endemic goiter and analysis of different indicators of iodine status region-wide. J Endocrinol Invest 2002, 25: 201-7. (Pubitemid 34295873)
15. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008, 29: 76-131. (Pubitemid 351252748)
16. Hegedüs L. Thyroid ultrasound. Endocrinol Metab Clin North Am 2001, 30: 339-60. (Pubitemid 32606678)
17. Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am 2001, 30: 315-37. (Pubitemid 32606677)
18. Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q 2006, 22: 231-8. (Pubitemid 44912329)
19. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in non-palpable thyroid nodules: predictive value of ultrasound and color-Doppler features J Clin Endocrinol Metab 2002, 87: 1941-6. (Pubitemid 34521470)
20. Mellor CS. Nomogram for calculating mass of alcohol in different beverages. Br Med J 1970, 3: 703.
21. Van Keymeulen A, Dumont JE, Roger PP. TSH induces insulin receptors that mediate insulin costimulation of growth in normal human thyroid cells. Biochem Biophys Res Commun 2000, 279: 202-7.
22. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models Endocr Rev 2001, 22: 631-56. (Pubitemid 32955247)
23. Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 1992, 72: 667-97.
24. Sari R, Balci MK, Altunbas H, Karayalcin U. The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol 2003, 59: 258-62. (Pubitemid 36918663)
25. Gómez JM, Maravall FJ, Gómez N, Gumà A, Soler J. Determinants of thyroid volume as measured by ultrasonography in healthy adults randomly selected. Clin Endocrinol 2000, 53: 629-34.
26. Barrère X, Valeix P, Preziosi P, et al. Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort. Clin Endocrinol (Oxf) 2000, 52: 273-8. (Pubitemid 30169682)
27. Mariotti S, Franceschi C, Cossarizza A, Pinchera A. The aging thyroid. Endocr Rev 1995; 16: 686-715.
28. Rotondi M, Amato G, Biondi B, et al. Parity as a thyroid size-determining factor in areas with moderate iodine deficiency. J Clin Endocrinol Metab 2000, 85: 4534-7. (Pubitemid 32157629)
29. Rotondi M, Sorvillo F, Mazziotti G, et al. The influence of parity on multinodular goiter prevalence in areas with moderate iodine deficiency. J Endocrinol Invest 2002, 25: 442-6. (Pubitemid 34516591)
30. Vigersky RA, Filmore-Nassar A, Glass AR. Thyrotropin suppression by metformin. J Clin Endocrinol Metab 2006, 91: 225-7. (Pubitemid 43069142)
31. Yandell SD, Harvey WC, Fernandes NJ, Barr PW, Feldman M. Radioiodine studies low serum thyrotropin, and the influence of statin drugs. Thyroid 2008, 18: 1039-42.
32. Wiersinga WM. Propranolol and thyroid hormone metabolism. Thyroid 1991, 1: 273-7.
33. Tognini S, Marchini F, Dardano A, et al. Non-thyroidal illness syndrome and short-term survival in a hospitalised older population. Age Ageing 2010, 39: 46-50.
34. Rendina D, Gianfrancesco F, De Filippo G, et al. Epidemiological, clinical and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy. J Endocrinol Invest 2010, 33: 519-25.
35. Rendina D, Mossetti G, De Filippo G, et al. Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant 2009, 24: 900-6.